KR970705387A - 자궁내막암의 억제 방법(methods of inhibiting endometrial cancer) - Google Patents
자궁내막암의 억제 방법(methods of inhibiting endometrial cancer)Info
- Publication number
- KR970705387A KR970705387A KR1019970701095A KR19970701095A KR970705387A KR 970705387 A KR970705387 A KR 970705387A KR 1019970701095 A KR1019970701095 A KR 1019970701095A KR 19970701095 A KR19970701095 A KR 19970701095A KR 970705387 A KR970705387 A KR 970705387A
- Authority
- KR
- South Korea
- Prior art keywords
- endometrial cancer
- compound
- methods
- inhibiting endometrial
- inhibiting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29385394A | 1994-08-22 | 1994-08-22 | |
| US08/293,853 | 1994-08-22 | ||
| PCT/US1995/010651 WO1996005833A1 (en) | 1994-08-22 | 1995-08-21 | Methods of inhibiting endometrial cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR970705387A true KR970705387A (ko) | 1997-10-09 |
Family
ID=23130867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019970701095A KR970705387A (ko) | 1994-08-22 | 1995-08-21 | 자궁내막암의 억제 방법(methods of inhibiting endometrial cancer) |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0777476A4 (xx) |
| JP (1) | JPH10504824A (xx) |
| KR (1) | KR970705387A (xx) |
| AU (1) | AU688112B2 (xx) |
| CA (1) | CA2198119A1 (xx) |
| CZ (1) | CZ51897A3 (xx) |
| FI (1) | FI970717A0 (xx) |
| HU (1) | HUT76890A (xx) |
| IL (1) | IL115022A (xx) |
| MX (1) | MX9701327A (xx) |
| MY (1) | MY113757A (xx) |
| NO (1) | NO970783D0 (xx) |
| NZ (1) | NZ292017A (xx) |
| RU (1) | RU2161964C2 (xx) |
| TW (1) | TW404834B (xx) |
| WO (1) | WO1996005833A1 (xx) |
| ZA (1) | ZA956994B (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5856340A (en) * | 1995-02-28 | 1999-01-05 | Eli Lilly And Company | Method of treating estrogen dependent cancers |
| US6465445B1 (en) | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| US7005428B1 (en) | 1998-06-11 | 2006-02-28 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| KR20160066490A (ko) * | 2014-12-02 | 2016-06-10 | 주식회사 씨앤드씨신약연구소 | 헤테로사이클 유도체 및 그의 용도 |
| CN115825414B (zh) * | 2023-01-09 | 2023-04-25 | 中国医学科学院北京协和医院 | 血液或尿液代谢标志物及其在子宫内膜癌早筛中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
| JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
| US5482949A (en) * | 1993-03-19 | 1996-01-09 | Eli Lilly And Company | Sulfonate derivatives of 3-aroylbenzo[b]thiophenes |
| WO1994023068A1 (en) * | 1993-04-07 | 1994-10-13 | Ligand Pharmaceuticals, Incorporated | Method for screening for receptor agonists |
| ATE220323T1 (de) * | 1993-10-15 | 2002-07-15 | Lilly Co Eli | Methode zur behandlung von resistenten neoplasmen |
| WO1996005832A1 (en) * | 1994-08-22 | 1996-02-29 | Eli Lilly And Company | Methods of inhibiting primary endometrial hyperplasia |
| US5843964A (en) * | 1994-09-22 | 1998-12-01 | Eli Lilly And Company | Methods of inhibiting endometrial mitoses |
-
1995
- 1995-08-21 EP EP95930243A patent/EP0777476A4/en not_active Withdrawn
- 1995-08-21 TW TW084108700A patent/TW404834B/zh not_active IP Right Cessation
- 1995-08-21 CA CA002198119A patent/CA2198119A1/en not_active Abandoned
- 1995-08-21 KR KR1019970701095A patent/KR970705387A/ko not_active Application Discontinuation
- 1995-08-21 MY MYPI95002449A patent/MY113757A/en unknown
- 1995-08-21 AU AU33700/95A patent/AU688112B2/en not_active Ceased
- 1995-08-21 JP JP8508265A patent/JPH10504824A/ja active Pending
- 1995-08-21 HU HU9701499A patent/HUT76890A/hu unknown
- 1995-08-21 ZA ZA9506994A patent/ZA956994B/xx unknown
- 1995-08-21 MX MX9701327A patent/MX9701327A/es unknown
- 1995-08-21 NZ NZ292017A patent/NZ292017A/en unknown
- 1995-08-21 IL IL11502295A patent/IL115022A/xx not_active IP Right Cessation
- 1995-08-21 CZ CZ97518A patent/CZ51897A3/cs unknown
- 1995-08-21 WO PCT/US1995/010651 patent/WO1996005833A1/en not_active Application Discontinuation
- 1995-08-21 RU RU97104160/14A patent/RU2161964C2/ru active
-
1997
- 1997-02-20 FI FI970717A patent/FI970717A0/fi unknown
- 1997-02-20 NO NO970783A patent/NO970783D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW404834B (en) | 2000-09-11 |
| FI970717A (fi) | 1997-02-20 |
| NO970783L (no) | 1997-02-20 |
| IL115022A (en) | 2000-07-31 |
| FI970717A0 (fi) | 1997-02-20 |
| RU2161964C2 (ru) | 2001-01-20 |
| AU688112B2 (en) | 1998-03-05 |
| IL115022A0 (en) | 1998-06-15 |
| EP0777476A4 (en) | 1999-06-23 |
| ZA956994B (en) | 1997-02-21 |
| HUT76890A (en) | 1997-12-29 |
| CA2198119A1 (en) | 1996-02-29 |
| WO1996005833A1 (en) | 1996-02-29 |
| MX9701327A (es) | 1997-05-31 |
| JPH10504824A (ja) | 1998-05-12 |
| NZ292017A (en) | 2000-07-28 |
| NO970783D0 (no) | 1997-02-20 |
| CZ51897A3 (en) | 1997-06-11 |
| EP0777476A1 (en) | 1997-06-11 |
| AU3370095A (en) | 1996-03-14 |
| MY113757A (en) | 2002-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR950016732A (ko) | 피부 및 질의 위축 억제방법 | |
| KR950016725A (ko) | 폐 고혈압성 질병을 억제하는 방법 | |
| KR950016738A (ko) | 알쯔하이머 질병의 억제 방법 | |
| KR970706818A (ko) | 뉴로펩티드 y와 관련된 상태의 억제 방법(methods of inhibiting conditions associated with neuropeptide) | |
| KR950010893A (ko) | 자궁내막증 억제 방법 | |
| KR950016744A (ko) | 트롬빈을 저해하는 방법 | |
| KR950016745A (ko) | 생리증상의 치료방법 및 이를 위한 조성물 | |
| KR950016746A (ko) | 비-펩티드 타키키닌 수용체 길항물질 | |
| KR950010892A (ko) | 자궁 섬유증 억제 방법 | |
| KR950016731A (ko) | 지루 및 좌창의 억제 방법 | |
| KR950016723A (ko) | 자가면역 질병의 억제 방법 | |
| KR950031069A (ko) | 골손실의 억제 및 혈청 콜레스테롤의 강하 방법 | |
| KR950016726A (ko) | 기능부전성 자궁 출혈을 억제하는 방법 | |
| KR950016724A (ko) | 폐경기 후 여성의 리비도를 증가시키는 방법 | |
| KR950017949A (ko) | 벤조티오펜 화합물과 수용성 사이클로덱스트린의 수용성 내포착물, 및 그의 약학제제 및 제조 방법 | |
| KR950010889A (ko) | 혈관형성 및 혈관형성성 질병을 억제하는 방법 | |
| KR950016740A (ko) | 조직의 불완전한 회복을 저해하는 방법 | |
| KR950016730A (ko) | 폐경기 후 증후군과 관련한 혈관 운동 증상 및 수반되는 심리학적 장애의 억제 방법 | |
| KR950016727A (ko) | 트롬보모듈린 발현을 증가시키는 방법 | |
| KR950010891A (ko) | 내성 종양을 치료하는 방법 | |
| KR970705384A (ko) | 골 보철 파손의 억제 방법(methods for inhibiting bone prosthesis degeneration) | |
| KR950016742A (ko) | 폐경후 여성의 씨엔에스 질환을 억제하는 방법 | |
| KR950010887A (ko) | 연골 퇴화 억제 방법 | |
| KR950016734A (ko) | 성적 조숙증의 억제방법 | |
| KR950016735A (ko) | 터너 증후군의 억제 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E601 | Decision to refuse application |